StoxNephro Care India Limited
NSE: NEPHROCARE · Unclassified
Ask the data
Instant answers about Nephro Care India Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 88.7 |
| EBITDA | 8.3 |
| Operating margin | 9.4% |
| Interest | 0.2 |
| Depreciation | 5.1 |
| Profit before tax | 4.6 |
| Tax | 1.3 |
| Net profit | 3.4 |
| EPS ₹ | 2.04 |
| Operating cash flow | 2.2 |
| Capex | 7.7 |
| Dividend paid | 0.0 |
| Total assets | 72.7 |
| Equity | 56.9 |
Half-yearly performance
last 2 half years · ₹ crore| H1 FY26* | H2 FY26 | |
|---|---|---|
| Revenue | 39.3 | 49.4 |
| Operating profit | 4.4 | 3.9 |
| Operating margin | 11.1% | 8.0% |
| Other income | 0.6 | 0.9 |
| Interest | 0.1 | 0.0 |
| Depreciation | 2.1 | 3.0 |
| Profit before tax | 2.8 | 1.9 |
| Tax | 0.8 | 0.4 |
| Net profit | 1.9 | 1.4 |
| EPS ₹ | 1.17 | 0.87 |
Returns & margins
trailing-twelve-month, per half year| H2 FY26 | |
|---|---|
| ROE | 5.9% |
| ROCE | 8.4% |
| Net margin | 3.8% |
| EBITDA margin | 9.4% |
| Debt / equity | 0.00 |
| Interest coverage | 30.00 |
| Asset turnover | 1.22 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '26 | |
|---|---|
| Share capital | 16.5 |
| Other equity / reserves | 40.4 |
| Total equity | 56.9 |
| Borrowings | 0.0 |
| Current liabilities | 15.3 |
| Non-current liabilities | 0.5 |
| Total assets | 72.7 |
| Property, plant & equipment | 34.0 |
| Investments | 11.8 |
| Inventories | 2.3 |
| Receivables | 6.0 |
| Cash & equivalents | 6.5 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | 2.2 |
| Cash from investing | -0.4 |
| Cash from financing | 0.1 |
| Capex | 7.7 |
| Free cash flow | -5.5 |
| Dividends paid | 0.0 |
Where the assets sit
Mar '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Nephro Care India Limited | 126 | 76.25 | 37.3 | 2.21 | 5.9% |
StoxGud checklist: Bearish setup · 2/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Nephro Care India Limited?
Nephro Care India Limited (NEPHROCARE) closed at ₹76.25 on NSE on 06 Nov 2026.
What is the market cap of Nephro Care India Limited?
₹126 crore at the latest close.
What is the P/E ratio of Nephro Care India Limited?
37.3, on trailing-twelve-month earnings from its filings.
How fast is Nephro Care India Limited growing?
Not enough filed history yet to measure Nephro Care India Limited's growth.
How profitable is Nephro Care India Limited?
On a trailing-twelve-month basis return on equity is 5.9%, return on capital employed 8.4%, operating margin 9.4%, net margin 3.8%.
How much debt does Nephro Care India Limited have?
Nephro Care India Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹6 cr (balance sheet of 2026-03-31). Operating profit covers interest 30.0 times.
Financials parsed from Nephro Care India Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Mar '26. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.